CADAS138 emerges as a novel therapeutic target in the realm of neurodegenerative diseases. Preclinical studies indicate significant potential for CADAS138-targeted therapies to mitigate disease progression. Researchers are actively exploring the underlying pathways of CADAS138 in disease pathogenesis, paving the way for the creation of novel the… Read More